Monday, July 11, 2005

DNA

NEW YORK, July 11 (Reuters) - Genentech Inc. (DNA.N: Quote, Profile, Research) , coming off a run of recent clinical successes, on Monday reported quarterly profit rose on strong sales of its cancer treatments.

The world's second-largest biotechnology company said it now expects 2005 earnings growth, excluding items, of at least 35 percent over 2004 levels.
Genentech posted a second-quarter profit of $296.2 million, or 27 cents per share, compared with a profit of $170.8 million, or 16 cents, a year ago.

0 Comments:

Post a Comment

<< Home

Search Engine Submission and Search Engine Optimization

Disclaimer: This website may include stock market analysis. Any ideas or opinions expressed by us is for informational purposes. Trade at your own financial risk as we assume no responsibility for your investing decisions in the markets. Blogarama - The Blogs Directory BlogRankers.com Business Blog Top Sites TopBlog.ws - Top 
Blog, Directory and Search Engine <